{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T07:55:10Z","timestamp":1721116510909},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,9,26]],"date-time":"2011-09-26T00:00:00Z","timestamp":1316995200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Urban South-Asian's are predisposed to early onset of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). There is an urgent need for country specific primary prevention strategies to address the growing burden of cardio-metabolic disease in this population. The aim of this clinical trial is to evaluate whether intensive (3-monthly) lifestyle modification advice is superior to a less-intensive (12 monthly; control group) lifestyle modification advice on a primary composite cardio-metabolic end point in 'at risk' urban subjects aged between 5-40 years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods\/Design<\/jats:title><jats:p>This is an open randomised controlled parallel group clinical trial performed at a single centre in Colombo, Sri-Lanka. A cluster sampling strategy was used to select a large representative sample of subjects aged between 5-40 years at high risk of T2DM and CVD for the intervention study. We have screened 23,298 (males 47% females 53%) healthy subjects for four risk factors: obesity, elevated waist circumference, family history of diabetes and physical inactivity, using a questionnaire and anthropometry. Those with two or more risk-factors were recruited to the intervention trial. We aim to recruit 4600 subjects for the intervention trial. The primary composite cardio-metabolic end point is; new onset T2DM, impaired glucose tolerance, impaired fasting glycaemia, new onset hypertension and albuminuria, following 5 years of intervention. The effect of the intervention on pre-specified secondary endpoints will also be evaluated. The study will be conducted according to good clinical and ethical practice, data analysis and reporting guidelines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>DIABRISK-SL is a large population based trial to evaluate the prevalence of diabetes, pre-diabetes and cardio-metabolic risk factors among young urban Sri-Lankans and the effect of a primary prevention strategy on cardio-metabolic disease end points. This work will enable country specific and regional cardio-metabolic risk scores to be derived. Further if the proposed intervention is successful the results of this study can be translated and implemented as a low-cost primary prevention tool in Sri-Lanka and other low\/middle income developing countries.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>The trial is registered with the World Health Organisation and Sri-Lanka clinical trial registry number SLCTR\/2008\/003<\/jats:p><\/jats:sec>","DOI":"10.1186\/1745-6215-12-209","type":"journal-article","created":{"date-parts":[[2011,9,27]],"date-time":"2011-09-27T06:38:27Z","timestamp":1317105507000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["DIABRISK - SL Prevention of cardio-metabolic disease with life style modification in young urban Sri Lankan's - study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"12","author":[{"given":"Mahen","family":"Wijesuriya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Gulliford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laksha","family":"Vasantharajah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Viberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Gnudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janaka","family":"Karalliedde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,26]]},"reference":[{"key":"745_CR1","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S0140-6736(09)60937-5","volume":"30","author":"A Ramachandran","year":"2010","unstructured":"Ramachandran A, Ma RCW, Snehalatha C: Diabetes in Asia. Lancet. 2010, 30: 408-18. 375","journal-title":"Lancet"},{"key":"745_CR2","first-page":"16","volume-title":"Diabetes Atlas","author":"R Sicree","year":"2006","unstructured":"Sicree R, Shaw J, Zimmet P: Prevalence and projections. Diabetes Atlas. Edited by: Gan D. 2006, International Diabetes Federation, Brussels, 16-104. 3","edition":"3"},{"key":"745_CR3","unstructured":"Department of Census and Statistics. 2001, Census Report - 2001, Ministry of Finance and Planning, Sri Lanka"},{"key":"745_CR4","first-page":"1062","volume-title":"Diabetic Medicine","author":"P Katulanda","year":"2008","unstructured":"Katulanda P, Constantine GR, Mahesh JG, Sheriff R, Seneviratne RDA, Wijeratne S, Wijesuriya M, McCarthy MI, Adler AI, Matthews DR: Prevalence and projections of diabetes and pre-diabetes in adults in Sri Lanka--Sri Lanka Diabetes. Diabetic Medicine. 2008, Cardiovascular Study (SLDCS), 25: 1062-9. 10.1111\/j.1464-5491.2008.02523.x."},{"key":"745_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002, 346: 393-403.","journal-title":"N Engl J Med"},{"key":"745_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00125-005-0097-z","volume":"49","author":"A Ramachandran","year":"2006","unstructured":"Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V: The Indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006, 49: 289-97. 10.1007\/s00125-005-0097-z.","journal-title":"Diabetologia"},{"key":"745_CR7","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","volume":"344","author":"J Tuomilehto","year":"2001","unstructured":"Tuomilehto J, Lindstr\u00f6m J, Eriksson JG, Valle TT, Ham\u00e4l\u00e4inen H, Ilanne-parikka P, Kein\u00e4nen-kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001, 344: 1343-1350. 10.1056\/NEJM200105033441801.","journal-title":"N Engl J Med"},{"key":"745_CR8","volume-title":"BMJ","author":"CL Gillies","year":"2007","unstructured":"Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, Khunti K: Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ. 2007, 334.299:"},{"key":"745_CR9","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/S0140-6736(06)69701-8","volume":"368","author":"J Lindstrom","year":"2006","unstructured":"Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, Hamalainen H, Harkonen P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle TT, Uusitupa M, Tuomilehto J, Finnish Diabetes Prevention Study Group: Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006, 368: 1673-9. 10.1016\/S0140-6736(06)69701-8.","journal-title":"Lancet"},{"key":"745_CR10","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/S0140-6736(08)60766-7","volume":"371","author":"G Li","year":"2008","unstructured":"Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Li H, Jiang Y, An Y, Shuai Y, Zhang Bo, Zhang J, Thompson TJ, Gerzoff RB, Roglic G, Hu Y, Bennett PH: The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008, 371: 1783-9. 10.1016\/S0140-6736(08)60766-7.","journal-title":"Lancet"},{"key":"745_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"KG Alberti","year":"2006","unstructured":"Alberti KG, Zimmet P, Shaw J: Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006, 23: 469-80. 10.1111\/j.1464-5491.2006.01858.x.","journal-title":"Diabet Med"},{"key":"745_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1399-5448.2007.00271.x","volume":"8","author":"P Zimmet","year":"2007","unstructured":"Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S, IDF Consensus Group: The metabolic syndrome in children and adolescents-an IDF consensus report. Pediatr Diabetes. 2007, 8: 299-306. 10.1111\/j.1399-5448.2007.00271.x.","journal-title":"Pediatr Diabetes"},{"key":"745_CR13","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003, 42: 1206-52. 10.1161\/01.HYP.0000107251.49515.c2.","journal-title":"Hypertension"},{"key":"745_CR14","first-page":"1","volume-title":"Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Part 1: Diagnosis and Classifi cation of Diabetes Mellitus. Geneva","author":"World Health Organization","year":"1999","unstructured":"World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Part 1: Diagnosis and Classifi cation of Diabetes Mellitus. Geneva. 1999, WHO Department of Noncommunicable Disease Surveillance, 1-59. http:\/\/www.who.int"},{"key":"745_CR15","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.2337\/diacare.26.12.3331","volume":"26","author":"S Genuth","year":"2003","unstructured":"Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Hahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P: Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003, 26: 3160-3167.","journal-title":"Diabetes Care"},{"key":"745_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.precon.2007.08.002","volume":"3","author":"C Arambepola","year":"2008","unstructured":"Arambepola C, Fernando D, Ekanayake R: A simple valid tool for measuring obesity-related-CHD risk in Sri Lankan adults. Prevention and Control. 2008, 3: 11-19. 10.1016\/j.precon.2007.08.002.","journal-title":"Prevention and Control"},{"key":"745_CR17","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JBW: The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001, 16: 606-13. 10.1046\/j.1525-1497.2001.016009606.x.","journal-title":"J Gen Intern Med"},{"key":"745_CR18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2307\/2136404","volume":"24","author":"S Cohen","year":"1983","unstructured":"Cohen S, Kamarck T, Mermelstein R: A global measure of perceived stress. Journal of Health and Social Behavior. 1983, 24: 385-96. 10.2307\/2136404.","journal-title":"Journal of Health and Social Behavior"},{"key":"745_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4038\/jccpsl.v11i2.8252","volume":"11","author":"KADDVL Kumarapeli","year":"2006","unstructured":"Kumarapeli KADDVL: Validation of WHOQOL-BREF to measure quality of life among women with polycystic ovary syndrome (PCOS). Journal of College of Community Physicians of Sri Lanka. 2006, 11: 1-10.","journal-title":"Journal of College of Community Physicians of Sri Lanka"},{"key":"745_CR20","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.2337\/dc07-0150","volume":"30","author":"A Ramachandran","year":"2007","unstructured":"Ramachandran A, Snehalatha C, Yamuna A, Mary S, Ping Z: Cost Effectiveness of the Interventions in the Primary Prevention of Diabetes among Asian Indians: Within trial results of the Indian Diabetes Prevention Programme (IDPP). Diabetes Care. 2007, 30: 2548-52. 10.2337\/dc07-0150.","journal-title":"Diabetes Care"},{"key":"745_CR21","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1136\/bmj.320.7244.1240","volume":"320","author":"TJ Cole","year":"2000","unstructured":"Cole TJ, Bellizzi MC, Flegal KM, Dietz WH: Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000, 320: 1240-3. 10.1136\/bmj.320.7244.1240.","journal-title":"BMJ"},{"key":"745_CR22","first-page":"i","volume":"894","author":"WHO","year":"2000","unstructured":"WHO: Obesity: preventing and managing the global epidemic. World Health Organ Tech Rep Ser. 2000, 894: i-xii. 1-253, Report of a WHO consultation","journal-title":"World Health Organ Tech Rep Ser"},{"key":"745_CR23","volume-title":"Prevalence of central obesity, raised body mass index, physical inactivity and family history of type 2 diabetes in young urban persons in Sri Lanka (DIABRISK SL stage 1)","author":"M Wijesuriya","year":"2009","unstructured":"Wijesuriya M: Prevalence of central obesity, raised body mass index, physical inactivity and family history of type 2 diabetes in young urban persons in Sri Lanka (DIABRISK SL stage 1). 2009, International Diabetes Federation, Montreal Canada October"},{"key":"745_CR24","doi-asserted-by":"publisher","first-page":"660","DOI":"10.2471\/BLT.07.043497","volume":"85","author":"M de Onis","year":"2007","unstructured":"de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J: Development of a WHO growth reference for school-aged children and adolescents. Bulletin of the World Health Organization. 2007, 85: 660-7. 10.2471\/BLT.07.043497.","journal-title":"Bulletin of the World Health Organization"},{"key":"745_CR25","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RK: Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985, 28: 412-419. 10.1007\/BF00280883.","journal-title":"Diabetologia"},{"issue":"2","key":"745_CR26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","volume":"58","author":"GJ Schwartz","year":"1976","unstructured":"Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A: A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976, 58 (2): 259-63.","journal-title":"Pediatrics"},{"key":"745_CR27","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999, 130: 461-70.","journal-title":"Ann Intern Med"},{"key":"745_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4278\/0890-1171-12.1.38","volume":"12","author":"JO Prochaska","year":"1997","unstructured":"Prochaska JO, Velicer WF: The transtheoretical model of health behaviour change. American Journal of Health Promotion. 1997, 12: 38-48.","journal-title":"American Journal of Health Promotion"},{"key":"745_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1037\/0278-6133.13.1.39","volume":"13","author":"JO Prochaska","year":"1994","unstructured":"Prochaska JO, Velicer WF, Rossi JS, Goldstein MG, Marcus BH, Rakowski W, Fiore C, Harlow LL, Redding CA, Rosenbloom D: Stages of change and decisional balance for 12 problem behaviours. Health Psychology. 1994, 13: 39-46.","journal-title":"Health Psychology"},{"key":"745_CR30","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s00125-009-1620-4","volume":"53","author":"RK Simmons","year":"2010","unstructured":"Simmons RK, Alberti KG, Gale EA, Colagiuri S, Tuomilehto J, Qiao Q, Ramachandran A, Tajima N, Brajkovich Mirchov I, Ben-Nakhi A, Reaven G, Hama Sambo B, Mendis S, Roglic G: The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia. 2010, 53: 600-5. 10.1007\/s00125-009-1620-4.","journal-title":"Diabetologia"},{"key":"745_CR31","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(07)61701-2","volume":"370","author":"R Horton","year":"2007","unstructured":"Horton R: Chronic diseases: the case for urgent global action. Lancet. 2007, 370: 1881-188. 10.1016\/S0140-6736(07)61701-2.","journal-title":"Lancet"},{"key":"745_CR32","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrcardio.2009.171","volume":"6","author":"S Mendis","year":"2009","unstructured":"Mendis S, Fuster V: National policies and strategies for noncommunicable diseases. Nature Reviews Cardiology. 2009, 6: 723-727. 10.1038\/nrcardio.2009.171.","journal-title":"Nature Reviews Cardiology"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-12-209.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1745-6215-12-209\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-12-209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-12-209.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T01:58:23Z","timestamp":1686362303000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-12-209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,26]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["745"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-12-209","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,26]]},"assertion":[{"value":"12 May 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"209"}}